Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 6;24(1):32.
doi: 10.1186/s12903-023-03632-5.

Do patients with cN0 oral squamous cell carcinoma benefit from elective neck dissection? A large-scale population-based study

Affiliations

Do patients with cN0 oral squamous cell carcinoma benefit from elective neck dissection? A large-scale population-based study

Qiuyu Wu et al. BMC Oral Health. .

Abstract

Background: The neck management of clinical-nodal negative (cN0) oral squamous cell carcinoma (OSCC) remains controversial. Elective neck dissection (END) and observation are the main strategies, but it is still not clear who could benefit the most from END. The purpose of this study was to clarify the potential clinical factors that affect the therapeutic value of END and to explore the actual characteristics associated with benefit from END.

Methods: Patients with cN0 OSCC were identified in the SEER database from 2000 to 2019. 5-year Overall survival (OS) and disease-specific survival (DSS) were analyzed using the Kaplan‒Meier method, and the hazard ratios (HRs) for survival were estimated using the Cox regression model. Multiple subgroup analyses of DSS and OS among different factors, comparing END and No END, were performed.

Results: A total of 17,019 patients with cN0 OSCC were included. The basic survival analysis and Cox regression model showed that END increased the probability of 5-year DSS and OS and was an independent prognostic factor. However, among patients who underwent only primary tumor surgery, no significant differences were found between the END and No END groups in 5-year DSS (P = 0. 585) and OS (P = 0.465). Further subgroup analysis showed that primary sites and T stage, but not other factors, might influence the benefit of END. Significant differences were found for T1 (P < 0.001 for OS) and T2 (P = 0.001 for DSS and < 0.001 for OS) tongue squamous cell carcinoma (TSCC) but not for other primary tumor sites.

Conclusion: This large-scale retrospective population-based cohort study suggests that not all patients with cN0 OSCC could benefit from END. Patients with cN0 TSCC are recommended to undergo END, especially with early-stage tumors.

Keywords: Clinical-nodal negative; Disease-specific survival; Elective neck dissection; Multiple subgroup analyses; Oral squamous cell carcinoma; Overall survival; SEER database.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
DSS (A) and OS (B) curves of patients with cN0 OSCC with or without END. Abbreviations: DSS Disease-specific survival, END Elective neck dissection, OS Overall survival, OSCC Oral squamous cell carcinoma
Fig. 2
Fig. 2
DSS (A) and OS (B) curves of patients with cN0 OSCC according to different treatment categories with END subgroup analysis. Abbreviations: DSS Disease-specific survival, END Elective neck dissection, OS Overall survival, OSCC Oral squamous cell carcinoma
Fig. 3
Fig. 3
Forest plots summarizing hazard ratios for DSS (A) and OS (B) of patients who only underwent primary site surgery without radiation and chemotherapy. Abbreviations: AI American Indian/Alaska Native, API Asian or Pacific Islander, B black, CI Confidence interval, DSS Disease-specific survival, END Elective neck dissection, HR Hazard ratio, MX Unknown M stage, OS Overall survival
Fig. 4
Fig. 4
Subgroup survival analysis of END in cN0 OSCC patients who only underwent primary site surgery without radiation and chemotherapy according to the primary site (AB) or T stage (C, D). Abbreviations: DSS Disease-specific survival, END Elective neck dissection, OS Overall survival, OSCC Oral squamous cell carcinoma
Fig. 5
Fig. 5
DSS (A) and OS (B) curves represent the cross-subgroup survival analysis of END in cN0 OSCC patients who only underwent primary site surgery without radiation and chemotherapy according to the primary sites and T stages. Abbreviations: DSS Disease-specific survival, END Elective neck dissection, OS Overall survival, OSCC Oral squamous cell carcinoma

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Pfister DG, Spencer S, Adelstein D, et al. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(7):873–98. - PubMed
    1. Warshavsky A, Rosen R, Nard-Carmel N, et al. Assessment of the Rate of Skip Metastasis to Neck Level IV in Patients with Clinically Node-Negative Neck Oral Cavity Squamous Cell Carcinoma: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2019;145:542–548. doi: 10.1001/jamaoto.2019.0784. - DOI - PMC - PubMed
    1. Roy P, Mallick I, Arun I, et al. Nodal yield and topography of nodal metastases from oral cavity squamous cell carcinoma - An audit of 1004 cases undergoing primary surgical resection. Oral Oncol. 2021;113:105115. doi: 10.1016/j.oraloncology.2020.105115. - DOI - PubMed
    1. Koyfman SA, Ismaila N, Crook D, et al. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline. J Clin Oncol. 2019;37:1753–1774. doi: 10.1200/JCO.18.01921. - DOI - PMC - PubMed

Publication types